BRAINSTORM CELL THERAPEUTICS INC. Increase (Decrease) in Due from Officers and Stockholders, Current
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Increase (Decrease) in Due from Officers and Stockholders, Current of $0 for the 129-month period ending 2011-06-30, per its 10-Q/A filed 2011-09-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromOfficersAndStockholdersCurrent · last filed 2011-09-07
- 2011-06-30: Increase (Decrease) in Due from Officers and Stockholders, Current 6 month $0.00; Increase (Decrease) in Due from Officers and Stockholders, Current 129 month $0.00.
- 2010-06-30: Increase (Decrease) in Due from Officers and Stockholders, Current 6 month -$25.00K.
| Period end | Increase (Decrease) in Due from Officers and Stockholders, Current 6 month | Increase (Decrease) in Due from Officers and Stockholders, Current 129 month |
|---|---|---|
| 2011-06-30 | $0.00 10-Q/A · filed 2011-09-07 | $0.00 10-Q/A · filed 2011-09-07 |
| 2010-06-30 | -$25.00K 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |